Categoría: Stem Cell Research
-
Legendary Texas Football Coach and Stem Cell Recipient Sam Harrell Returns to Coaching
In 2010, the debilitating effects of multiple sclerosis forced Sam Harrell to retire from his position as Head Football Coach at Ennis High School. But after receiving 3 courses of stem cell therapy at the Stem Cell Institute in Panama, Sam is returing to the gridiron once again. Brownwood Lion Head Coach, Bob Shipley announced…
-
Quality time: Former Ennis coach Sam Harrell is counting his blessings despite having multiple sclerosis
ENNIS, TX — Sam Harrell’s three state football championships are celebrated in his home office. He has pictures, trophies and balls, and even more memories. For 32 years, Harrell worked in a profession where success is measured by a scoreboard in front of thousands. These days, life’s little victories — unaccompanied by cheers or Gatorade…
-
First patient to get stem cell therapy identified
By Rob Stein, The Washington Post Embryonic stem cells have numerous pitfalls in addition to the ethical dilemmas. While the concept of a “blank slate” cell is extremely attractive in terms of generating new tissues for transplantation and organ replacement, the problem is that these cells are so young that they do not properly “know”…
-
«The fight to walk» – spinal cord injury patient improving after stem cell therapy in Panama
Published March 31, 2012 By Sue Guinn Legg – Press Staff Writer Daniel Leonard is doing all he can to walk again, and after a recent course of stem cell treatment he’s as close as he has been since a few months after the 2005 injury that put him a wheelchair. He was 22 years…
-
Great Day in Ft. Worth for Stem Cell Team
Saturday, March 31 was the annual MS Walk in Ft Worth. This year, thanks to the Stem Cell Institute and some of the area stem cell patients, several of us MS sufferers and stem cell patients met for the Walk. Here’s a picture of several of us who have been to Panama, or Costa Rica,…
-
Making Blood Cells into Heart Cells
Vojdani et al. Hum Cell. 2011 Mar;24(1):35-42 One of the major debates in the area of stem cell therapy is whether adult stem cells are capable of directly transforming (differentiating) into new tissue, or whether the therapeutic effects of administered stem cells occur because of growth factors produced by the injected stem cells. There are…
-
New stem cell study promises to heal the heart
Miami Herald, Fred Tasker ftasker@MiamiHerald.com University of Miami cardiologist led by Dr. Joshua Hare reported success in a small, preliminary human clinical trial of a new stem cell therapy they hope some day will routinely mend human hearts and reduce the need for lifelong medication, possibly even for transplants. The study was published in the…
-
Stemedica Treats First Patient with Ischemic Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies Press Release The San Diego stem cell company Stemedica Cell Technologies, Inc reported treatment of its first patient as part of a 35 patient clinical trial in stroke patients. The study uses bone marrow stem cells that have been preconditioned with hypoxia and used in a non-matched manner. The trial is being…
-
Medistem Signs Exclusive Worldwide License With Yale University for Treatment of Type 1 Diabetes Using Stem Cells
Acquisition of Intellectual Property and Data Leads to Expansion of Medistem Therapeutic Pipeline SAN DIEGO, CA, Mar 07, 2012 (MARKETWIRE via COMTEX) — Medistem Inc. (pinksheets:MEDS) and Yale University have signed an exclusive worldwide licensing agreement covering the generation of pancreatic islets from stem cells such as the Endometrial Regenerative Cell (ERC). These pancreatic islets…
-
Medistem Inc. to Add Kidney and Lung Failure to Clinical Trials of Endometrial Regenerative Cells (ERC) Stem Cells in Russia
SAN DIEGO, CA and PORTLAND, OR, Mar 05, 2012 (MARKETWIRE via COMTEX) — Medistem Inc. (pinksheets:MEDS), in partnership with its Russian licensee, ERCell, announced the signing of a letter of intent* to begin clinical trials using Medistem’s Endometrial Regenerative Cells (ERC) stem cells for renal, lung and peripheral artery disease. Trials will be conducted in…